脑室——腹腔分流术治疗脑积水的临床效果观察

The effect observation of ventricular-peritoneal shunt in treatment of hydrocephalus

目的观察脑室—腹腔分流术治疗脑积水患者的临床效果。方法将68例脑积水患者随机分为试验组和对照组各34例。试验组患者行脑室—腹腔分流术,对照组患者行常规手术治疗。治疗后对比2组手术时间、术后排气时间及手术前后双侧脑室额角差值,治疗前后脑室周围水肿带直径及并发症情况。结果试验组手术时间、术后排气时间均短于对照组,差异有统计学意义(P<0.05)。2组手术前后双侧脑室额角差值比较差异无统计学意义(P>0.05)。手术治疗前2组患者的脑室周围水肿带直径比较差异无统计学意义(P>0.05)。手术治疗后2组患者的脑室周围水肿带直径减小,但试验组小于对照组,差异均有统计学意义(P<0.05)。试验组并发症发生率为5.9%低于对照组的14.7%,差异有统计学意义(P<0.05)。结论脑室—腹腔分流术对脑积水患者的治疗效果较好,降低了术后并发症的发生,安全性较高,值得临床推广应用。

Objective To observe the effect of ventricular-peritoneal shunt in treatment of hydrocephalus. Methods 80 cases patients with hydrocephalus were randomly divided into test group and control group, each of 34 cases. Test group was treated by ventricular-peritoneal shunt, Control group was treated by conventional surgical treatment. After treatment, compared the operation time,postoperative discharge time and bilateral ventricular difference before and after surgery of 2 groups. Com- pared the periventricular edema with diameter before and after treatment and complication in 2 groups, Results The operation time, postoperative discharge time of test group was shorter than that of control group, the difference was statistic significantly （P 〈0.05）. The bilateral ventricular difference before and after surgery of 2 groups was no statistic significantly（P 〉 0.05 ）. The periventricular edema with diameter before treatment of 2 groups was no statistic significantly（ P 〉 0.05 ）. The periventricular edema with diameter after treatment of 2 group were less than that before treatment, and the periventricular edema with diameter after treatment of test group was less than that of control group, the difference was statistic significantly （P 〈 0.05 ）. The complication of test group （5.9 % ） was lower than that of control group （ 14.7% ）, the difference was statistic significantly （P 〈 0.05 ）. Conclusion Ventricular-peritoneal shunt in treatment of hydrocephalus has a good effect, can reduce the occurrence of postoperative complications, high safety, it is worthy of clinical application.